Supplemental material
OncoImmunology
Volume 5, 2016 - Issue 4
Open access
3,892
Views
57
CrossRef citations to date
0
Altmetric
Original Research
Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells
Pavel OtáhalDepartment of Hematology, Charles University General Hospital in Prague, Czech Republic;Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech RepublicCorrespondence[email protected]
, Dana PrůkováInstitute of Pathological Physiology, First Faculty of Medicine, Charles University in Prague, Czech Republic
, Vlastimil KrálInstitute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic
, Milan FabryInstitute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic
, Petra VočkováInstitute of Pathological Physiology, First Faculty of Medicine, Charles University in Prague, Czech Republic
, Lucie LatečkováInstitute of Pathological Physiology, First Faculty of Medicine, Charles University in Prague, Czech Republic
, Marek TrněnýDepartment of Hematology, Charles University General Hospital in Prague, Czech Republic
& Pavel KlenerDepartment of Hematology, Charles University General Hospital in Prague, Czech Republic;Institute of Pathological Physiology, First Faculty of Medicine, Charles University in Prague, Czech RepublicCorrespondence[email protected]
show all
Article: e1115940
|
Received 18 May 2015, Accepted 29 Oct 2015, Published online: 08 Apr 2016
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.